[PS9-2A-K] Precision medicine in epilepsy clinical practice
After cancer, epilepsy offers one of the best model to achieve precision medicine. The main cornerstones for that are the rapid progress in epilepsy gene discovery, the advance of good animal and in-vitro models allowing the development of medications tailored to genetically defined subtypes of epilepsy, the ability to evaluate efficacy of experimental targeted treatments in cost-effective clinical trials, and the gradually established National/International large scale multi-center research network. In near future, all types of likely non-acquired epilepsy will be assessed by genetic and molecular assay, after that, basic, clinical, and translational research will be closely integrated to drive the development of precise diagnosis and therapies to every individual with epilepsy.